You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -2.5 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 0.0 | n/a |
Price / Book value | 4.2 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 0.08 | -7.96 | -5.19p | -2.3 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 0.08 | -6.74 | -3.99p | -4.0 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 0.13 | -7.25 | 3.43p | 3.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 0.12 | -8.94 | -3.25p | -2.0 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | n/a | -4.46 | -1.26p | -1.5 | 0.0 | n/a | n/a | 0.0% |
ImmuPharma progresses P140 clinical programme with FDA Sharecast News | 12 Apr |
---|---|
ImmuPharma upbeat after meeting with US partner Avion Sharecast News | 11 Nov |
ImmuPharma's US partner receives FDA response on Lupuzor Sharecast News | 14 Sep |
IMM RNS Posting of RA and Notice of AGM 30 June 23 | 06-Jun-23 14:28 |
---|---|
Positive Pre-IND meeting with FDA | 18-May-23 14:36 |
Final Results | 11-May-23 14:46 |
Holding(s) in Company | 10-May-23 23:02 |
Lupozor Update - FDA confirms Type-C meeting date | 19-Apr-23 14:43 |